Patent · US Expired

Production of chimeric antibodies with specificity to human tumor antigens

US6461824B1 · kind B1 · utility

11Cited by
10References
198Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 6, 1995
Grant dateOct 8, 2002
Priority date
Expiry dateJun 6, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/40
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention is directed to chimeric immunoglobulins that recognize a human tumor antigen bound by antibody, ING-2, ING-3, ING-4 or KM10, the production of such chimeric immunoglobulins, and their use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.